Holen Sie sich die Stockscreener-App
1.24
36.08%
-0.70
Vorhandelsmarkt:
1.19
-0.05
-4.03%
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
41.69%
3.076
|
2.171 | 0.665 | 1.049 | 0.536 |
Operating Expenses
|
8.61%
41.73
|
38.42 | 37.38 | 33.67 | 34.65 |
| Interest Income/Expense |
1.47%
0.689
|
0.679 | 0.784 | 0.958 | 0.952 |
| Benefits Costs and Expenses |
100.00%
-
|
36.30 | 36.47 | - | - |
| Costs And Expenses |
14.96%
41.73
|
36.30 | 36.47 | 33.67 | 34.65 |
| Operating Income/Loss |
6.63%
-38.65
|
-36.25 | -36.71 | -32.62 | -34.11 |
| Income/Loss From Continuing Operations Before Tax |
109.01%
3.076
|
-34.13 | -35.81 | 1.049 | 0.536 |
| Income/Loss From Continuing Operations After Tax |
8.28%
-36.95
|
-34.13 | -35.81 | -29.89 | -31.66 |
|
Net Income/Loss
|
8.28%
-36.95
|
-34.13 | -35.81 | -29.89 | -31.66 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.04%
129.73
|
129.68 | 2.9545 | 118.70 | 113.43 |
| Diluted Average Shares |
0.04%
129.73
|
129.68 | 2.9545 | 118.70 | 113.43 |
| Basic Earnings Per Share |
7.69%
-0.28
|
-0.26 | -0.30 | -0.25 | -0.28 |
| Diluted Earnings Per Share |
7.69%
-0.28
|
-0.26 | -0.30 | -0.25 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):